Sanofi gets rated buy today ... I think could contribute to continued top-line performance is a diversified portfolio of ...

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

Janney Montgomery Scott LLC lessened its stake in Sanofi (NASDAQ:SNY – Free Report) by 0.3% in the third quarter, according ...

Sanofi India net profit down 46% in quarter ended September 30: Our Bureau, New Delhi Friday, November 8, 2024, 11:35 Hrs [IST] Sanofi India has registered 46 per cent decline in ...

Shares of Sanofi (NASDAQ:SNY – Get Free Report) have received a consensus rating of “Moderate Buy” from the four brokerages that are currently covering the stock, Marketbeat reports. Two analysts have ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Dupixent to Remain Sanofi's (SNY) Key Top-Line Driver The Zacks analyst expects Dupixent ... Decreased Demand Paper Related Products Hurts Xerox (XRX) Per the Zacks analyst, Xerox is grappling with ...

Saudi Arabia Pharmaceutical Drugs Market Projected To Witness Substantial Growth, 2024-2031: Pfizer Inc., Sanofi S. A. Saudi Arabia Pharmaceutical Drugs Market is estimated to be valued at US$ 12.60 ...

As head of HHS, Kennedy would lead a sprawling federal department that encompasses more than 100 programs supporting medicine ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including World <a target=_blank ...

Sanofi had no sooner announced the departure ... Le Chatelier took the top job at Ipsen on an interim basis last December after former CEO David Meek resigned from the company last year to take ...

PARIS, Oct 17 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said ... All candidates had the same opportunity to submit their best offers within the process deadline, the company ...